Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Prostate Cancer
 More »

  • Bayer Prostate Cancer Drug Gains FDA Approval
    Bayer HealthCare said yesterday it is weeks away from joining Algeta in bringing to the U.S. market their advanced prostate cancer drug Xofigo® (radium Ra 223 dichloride) ...
    5-16-2013
  • Mass Spec Provides Peek into PTMs
    ... "The method has been applied to multiple frozen tissues, with emphasis on human prostate cancer, renal cancer, and different therapeutic mouse xenograft cancer tissues. ...
    5-15-2013
  • Companion Diagnostics: 52 Pick-Up
    ... Wnt, and other pathways critical to the spread of cancer stem cells. OncoMed providing Genomic Health with breast, prostate, colon, and lung tumor samples, some of which will ...
    5-9-2013
  • Cancer Diagnostics, Pushing the Boundaries
    ... Loss of PTEN function has been associated with multiple cancers, including endometrial cancer, glioblastoma, melanoma, and prostate cancer. Loss of PTEN activity can result from ...
    5-8-2013
  • Two Proteins Found to Block Cancer Metastasis
    ... This peptide alone induced Tsp-1 in the bone marrow cells and effectively suppressed metastatic spread in the lungs in mouse models of breast and prostate cancer. This 5-amino acid ...
    5-1-2013
  • Biomarkers Take Center Stage
    ... Lysates," which showed the results of a survey of proteins relevant to colorectal (CRC) and prostate (PC) tumors to identify potential proteins of interest for cancer research. ...
    5-1-2013
  • Gene Expression Analysis in Living Cells
    ... miR-21 in both HEK-293 cells (typically used as a low expresser of miR-21) and in DU-145 (a prostate cancer cell line known to express high levels of miR-212) using flow cytometry. ...
    5-1-2013
  • Aeterna Zentaris Sharing Costs, Profits for Cancer Drug
    AEZS-108 is also being investigated in Phase II trials for triple-negative breast cancer, prostate cancer, and bladder cancer. AEZS-108 is a hybrid molecule composed of a synthetic ...
    4-10-2013
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... Medivation and Astellas Pharma Indication(s): Metastatic, castration-resistant prostate cancer in men who have previously received treatment with docetaxel Date of FDA approval: ...
    4-4-2013
  • Exploiting Folate Pathways to Treat Cancer
    ... Endocyte researchers also can replace folate with a different targeting ligand to attach to other receptors. One drug candidate targets a different receptor on prostate cancer ...
    4-1-2013
  • Major Advance: Novel DNA Cancer-Associated Variants Identified
    susceptible to contributing to the development of breast cancer, 23 new ones for prostate cancer, and four for ovarian cancer. "Specifically, the 41 new genes identified for ...
    3-28-2013
  • New Biomarkers Could Offer Vital Clues for Cancer Research
    (and risk indicator) for coronary and vascular disease, that C-reactive protein (CRP) is a biomarker for inflammation and prostate-specific antigen (PSA) for prostate cancer. ...
    3-21-2013
  • Dendreon, Plaintiffs Settle Class-Action Suit for $40M
    the troubled company two years ago by investors who alleged that it misled them about its finances, business operations, and prospects for its prostate cancer drug Provenge. ...
    3-18-2013
  • How Vitamin E Might Prevent Cancer
    The loss of the enzyme, called Akt, led to tumor cell death in prostate cancer cells. The vitamin had no negative effect on normal cells. The anticancer property of vitamin E has ...
    3-15-2013
  • Rise of Cell-Based Immunotherapy
    ... Provenge merely adds a survival advantage to hormone-refractory prostate cancer, but does not block death from the disease. Its per-patient price of $93,000 has been a deterrent ...
    3-1-2013
  • More »

    Journal Articles

  • Impaired Vitamin D Activation and Association with CYP24A1 Haplotypes...
    Marissa Penna-Martinez, Elizabeth Ramos-Lopez, Julienne Stern, Heinrich Kahles, Nora Hinsch, Martin-Leo Hansmann, Ivan Selkinski, Frank Grünwald, Christian Vorländer, Wolf O. Bechstein, Stefan Zeuzem, Katharina Holzer, Klaus Badenhoop
    Thyroid
    Background: Common polymorphisms of the vitamin D receptor gene have been reported to affect the risk of breast, colon, prostate, and differentiated thyroid cancer (DTC), but ...
  • High-Intensity Focused Ultrasound for Localized Thyroid-Tissue...
    Olivier Esnault, Brigitte Franc, Jean-Paul Monteil, Jean-Yves Chapelon
    Thyroid
    Methods: The ewe was chosen as the model because its thyroid is easily accessible, with a size comparable to the human gland. An HIFU device designed to treat human prostate cancer ...
  • Transabdominal Preperitoneal Robotic Inguinal Hernia Repair
    Fumito Ito, David Jarrard, Jon C. Gould
    Journal of Laparoendoscopic& Advanced Surgical Techniquesand Part B, Videoscopy
    Robotic prostatectomy is the fastest growing treatment of prostate cancer. Concurrent robotic prostatectomy and robotic inguinal hernia repair has not been previously described. We ...
  • The Expression of Monocyte Chemotactic Protein-1 in Papillary...
    Katsuhiro Tanaka, Junichi Kurebayashi, Mai Sohda, Tsunehisa Nomura, Uma Prabhakar, Li Yan, Hiroshi Sonoo
    Thyroid
    Background: Monocyte chemotactic protein-1 (MCP-1) is a chemokine ligand that has been associated with aggressive behavior in breast and prostate cancer. The present study was ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll